This site is intended for Healthcare Professionals only.

NPA’s HEF funds breakthrough research into medicines adherence


Share post:

The National Pharmacy Association (NPA)’s Health Education Foundation (HEF) has funded a major study that aimed to test the SPUR tool and evaluate how effective it was at measuring medicines adherence.

The study has been published in the British Medical Journal Open.

Dr Joshua Wells, a fourth year PhD candidate at Kingston University, who was awarded the NPA bursary, was the lead researcher for the SPUR UK study, under the guidance of Professor Reem Kayyali.

Created by Observia, a health research group, SPUR is a self-assessment questionnaire which helps to detect a patient’s risk of medicine non-adherence and aims to accurately articulate the reasons for health behavior.

As well as funding from HEF, the study was made possible via a partnership with Kingston University and Kingston Hospital.

HEF chair of Trustees, Dr Ian Cubbin, said: “We are delighted that NPA’s Health Education Foundation has played a part in such an important study. This research could lead ultimately to a far more personalized, tailored approach to medicines optimization – recognizing that people’s medicines behavior can be highly individual to them.”

The NPA’s HEF was established in 1989 to advance public education in the prevention and proper treatment of disease and ill-health. HEF has been successfully supporting community pharmacy practice research for thirteen years. The annual bursary aims to encourage pharmacists to undertake research in this area.



Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Over half a million dementia cases could go undiagnosed by 2040, study predicts

Currently, an estimated 850,000 people are living with dementia in the UK, with 315,000 undiagnosed cases As the...

GPhC explores potential benefits of covert surveillance powers

GPhc to address ethical concerns regarding covert surveillance, particularly in online pharmacy probes  In a recent minute of meeting,...

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety

PDA advocates pharmacist autonomy in professional leadership amid CPhO influence In a bid to bolster professional leadership within the...

Former NPA director Phil Galt named new Cegedim Rx UK managing director

Phill Galt replaces Adam Dennett who stepped down from the Cegedim Rx's leadership role after a successful ten-year...